Time course of action of sugammadex (Org 25969) on rocuronium-induced block in the Rhesus monkey, using a simple model of equilibration of complex formation.
暂无分享,去创建一个
[1] J. van Egmond,et al. Reversal of Profound Rocuronium Neuromuscular Blockade by Sugammadex in Anesthetized Rhesus Monkeys , 2006, Anesthesiology.
[2] J. van Egmond,et al. Sugammadex, a new reversal agent for neuromuscular block induced by rocuronium in the anaesthetized Rhesus monkey. , 2006, British journal of anaesthesia.
[3] J. van Egmond,et al. Chemical encapsulation of rocuronium by synthetic cyclodextrin derivatives: reversal of neuromuscular block in anaesthetized Rhesus monkeys. , 2006, British journal of anaesthesia.
[4] M. Giovannelli,et al. Org 25969 (sugammadex), a selective relaxant binding agent for antagonism of prolonged rocuronium-induced neuromuscular block. , 2006, British journal of anaesthesia.
[5] S. Ramael,et al. First Human Exposure of Org 25969, a Novel Agent to Reverse the Action of Rocuronium Bromide , 2005, Anesthesiology.
[6] P. Desmond,et al. Liquid chromatography/mass spectrometric bioanalysis of a modified gamma-cyclodextrin (Org 25969) and Rocuronium bromide (Org 9426) in guinea pig plasma and urine: its application to determine the plasma pharmacokinetics of Org 25969. , 2002, Rapid communications in mass spectrometry : RCM.
[7] S. Ramael,et al. Preliminary Assessment of Org 25969 as a Reversal Agent for Rocuronium in Healthy Male Volunteers: [2002][A-1008] , 2002 .
[8] J. Egmond,et al. Reversal agents for nondepolarizing neuromuscular blockade: Reasons for and development of a new concept , 2002 .
[9] Mark Bradley,et al. A novel concept of reversing neuromuscular block: chemical encapsulation of rocuronium bromide by a cyclodextrin-based synthetic host. , 2002, Angewandte Chemie.
[10] R. Mirakhur,et al. Postoperative residual block after intermediate‐acting neuromuscular blocking drugs , 2001, Anaesthesia.